The effect of isoniazid use for tuberculosis prevention on pregnancy incidence among women living with HIV on antiretroviral treatment and progestin-based hormonal contraception
Publication
, Conference
Diepstra, K; Westreich, D; Bula, A; Lemani, C; Chapola, J; Winston, J; Mollan, K; Hagey, J; Phiri, S; Chiwoko, J; Hosseinipour, M; Cottrell, M ...
Duke Scholars
Location
Halifax, Nova Scotia
Conference Name
ISPE’s 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Citation
APA
Chicago
ICMJE
MLA
NLM
Diepstra, K., Westreich, D., Bula, A., Lemani, C., Chapola, J., Winston, J., … Tang, J. (n.d.). The effect of isoniazid use for tuberculosis prevention on pregnancy incidence among women living with HIV on antiretroviral treatment and progestin-based hormonal contraception. Presented at the ISPE’s 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Halifax, Nova Scotia.
Diepstra, Karen, Daniel Westreich, Agatha Bula, Clara Lemani, John Chapola, Jennifer Winston, Katie Mollan, et al. “The effect of isoniazid use for tuberculosis prevention on pregnancy incidence among women living with HIV on antiretroviral treatment and progestin-based hormonal contraception,” n.d.
Diepstra K, Westreich D, Bula A, Lemani C, Chapola J, Winston J, et al. The effect of isoniazid use for tuberculosis prevention on pregnancy incidence among women living with HIV on antiretroviral treatment and progestin-based hormonal contraception. In.
Diepstra K, Westreich D, Bula A, Lemani C, Chapola J, Winston J, Mollan K, Hagey J, Phiri S, Chiwoko J, Hosseinipour M, Cottrell M, Pettifor A, Wood M, Tang J. The effect of isoniazid use for tuberculosis prevention on pregnancy incidence among women living with HIV on antiretroviral treatment and progestin-based hormonal contraception.
Location
Halifax, Nova Scotia
Conference Name
ISPE’s 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management